Materials and Methods
Sigma Aldrich Chemical company manufactured chemicals used in this research work. Suntex melting point apparatus was used for measuring melting point of all synthesized compounds and are uncorrected. The FT-IR spectra of all imines were recorded in Avatar-300 Thermo Nicolet Fourier Transform infrared spectrophotometer (4000-400cm− 1) using potassium bromide disc. The 1H NMR and 13C NMR spectra of all synthesized imines were recorded in BRUKER AVANCE III 500 MHz NMR spectrophotometer at 400 MHz for 1H NMR spectra and 100.61 MHz for 13C NMR spectra. Chloroform-D6 used as solvent with TMS as standard. The LCMS mass spectra of all compounds were recorded in the Water Micro TOF Qii spectrometer in EI mode. The CHN analysis results was obtained from VARIOMICRO V2.2.0 elemental analyzer.
General procedure for the Synthesis of E-imines (1–28)
An equal molar quantities of aryl amines (1 mmol) substituted benzaldehydes (1 mmol) and 0.3 mg of nano fly-ash H3PO4 catalyst [43] and 20 mL of ethanol were ultrasonicated in ultrasonication bath at 40 Hz, in room temperature for 6–13 m (Scheme 1) (Citizen Ultra Sonicator, 40 Hz, 120W, 240V, AC). The progress of the reaction was monitored using TLC. After completion of the reaction, the product was separated by simple filtration and evaporation of ethanol gave the crude product. The catalyst was washed with ethyl acetate and reused for further reactions. The crude was recrystallized with ethanol afforded the corresponding E-imines. The yield, time and physical constants of the synthesized imines are tabulated in Table 1.
Table 1
The physiochemical constants, time and yields of the synthesized E-imines
|
Entry | Ar | Ar′ | M.F. | M.W | Yield (%) | Time (m) | M.p. (˚C) |
1 | 4-Phenylmorpholine | Phenyl | C17H18N2O | 266 | 85 | 7 | 178–180 |
2 | 4-Phenylmorpholine | 3-Bromophenyl | C17H17BrN2O | 345 | 79 | 8 | 101–103 |
3 | 4-Phenylmorpholine | 4-Bromophenyl | C17H17BrN2O | 345 | 78 | 8 | 188–191 |
4 | 4-Phenylmorpholine | 3-Chlorophenyl | C17H17ClN2O | 301 | 81 | 8 | 110–112 |
5 | 4-Phenylmorpholine | 4-Chlorophenyl | C17H17ClN2O | 301 | 83 | 9 | 150–152 |
6 | 4-Phenylmorpholine | 4-Dimethylaminophenyl | C19H23N3O | 309 | 86 | 7 | 230–232 |
7 | 4-Phenylmorpholine | 4-Florophenyl | C17H17FN2O | 284 | 80 | 10 | 140–142 |
8 | 4-Phenylmorpholine | 3-Methoxyphenyl | C18H20N2O2 | 296 | 87 | 8 | 86–88 |
9 | 4-Phenylmorpholine | 2-Methylphenyl | C18H20N2O | 280 | 84 | 9 | 80–82 |
10 | 4-Phenylmorpholine | 4-Methylphenyl | C18H20N2O | 280 | 83 | 9 | 158–160 |
11 | 4-Phenylmorpholine | 4-Nitrophenyl | C17H17N3O3 | 311 | 75 | 12 | 199–201 |
12 | Phenyl | 2-Amino-4,6-dibromophenyl | C13H10Br2N2 | 354 | 78 | 13 | 136-137134-136[44] |
13 | 4-Bromophenyl | 2-Amino-4,6-dibromophenyl | C13H9Br3N2 | 432 | 76 | 10 | 197-198196-198[44] |
14 | 4-Chlorophenyl | 2-Amino-4,6-dibromophenyl | C13H9Br2ClN2 | 388 | 77 | 12 | 180-181182-184[44] |
15 | 4-Florophenyl | 2-Amino-4,6-dibromophenyl | C13H9Br2FN2 | 372 | 77 | 11 | 166-167164-166[44] |
16 | 4-Methoxyphenyl | 2-Amino-4,6-dibromophenyl | C14H12Br2N2O | 384 | 83 | 12 | 108-109106-108[44] |
17 | 4-Methylphenyl | 2-Amino-4,6-dibromophenyl | C14H12Br2N2 | 368 | 82 | 11 | 113-115114-116[44] |
18 | 1-Benzyl-4-piperidinyl | Phenyl | C19H22N2 | 278 | 81 | 8 | 66–67(64–65)[25] |
19 | 1-Benzyl-4-piperidinyl | 3-Bromophenyl | C19H21BrN2 | 357 | 79 | 9 | 60–61(59–60) [25] |
20 | 1-Benzyl-4-piperidinyl | 3-Chlorophenyl | C19H21ClN2 | 312 | 78 | 11 | 55–56(53–54) [25] |
21 | 1-Benzyl-4-piperidinyl | 4-Chlorophenyl | C19H21ClN2 | 312 | 79 | 10 | 103–104(102–103) [25] |
22 | 1-Benzyl-4-piperidinyl | 4-Dimethylaminophenyl | C21H27N2 | 321 | 86 | 11 | 58–59(57–58) [25] |
23 | 1-Benzyl-4-piperidinyl | 4-Fluorophenyl | C19H21FN2 | 296 | 80 | 11 | 94–95(92–93) [25] |
24 | 1-Benzyl-4-piperidinyl | 3-Methoxyphenyl | C20H24N2O | 308 | 86 | 9 | 64–65(63–64) [25] |
25 | 1-Benzyl-4-piperidinyl | 4-Methoxyphenyl | C20H24N2O | 308 | 84 | 7 | 51–52(49–50) [25] |
26 | 1-Benzyl-4-piperidinyl | 4-Methylphenyl | C20H24N2 | 292 | 83 | 9 | 54–55(51–52) [25] |
27 | 1-Benzyl-4-piperidinyl | 3-Nitrophenyl | C19H21N3O2 | 323 | 76 | 11 | 62–63(60–61) [25] |
28 | 1-Benzyl-4-piperidinyl | 4-Nitrophenyl | C19H21N3O2 | 323 | 77 | 12 | 84–85(82–83) [25] |
The spectroscopic data and elemental analysis of the E-imines (1–11) as summarized as follows.
( E )-N-Benzylidene-4-morpholinianilie (1): FT- IR (KBr, cm− 1); ν = 1623.44(C = N), 1232.03 (C-N), 2961.00(CH), 1448.91 (C-O-C). 1H NMR (400 MHz, CDCl3, ppm) δ = 8.498 (s, 1H, CH), 3.185 (s, 4H, N-(CH2)2), 3.879 (s, 4H, O-(CH2)2, 6.939–7.888(m, 9H, Ar-H). 13C NMR (100 MHz, CDCl3, ppm) δ = 157.91 (C = N), 49.50(N-CH2), 66.92(O-CH2), 116.18-149.95 (Ar-C). Anal. C (76.66), H (6.81), N (10.52); Found (%): C (76.61), H (6.77), N (10.50). LCMS (m/z) = 266 [M1+] 190, 189, 186, 180, 176, 104, 91, 78, 77, 27.
( E )-N-(3-Bromobenzylidene)-4-morpholinoaniline (2): FT- IR (KBr, cm− 1); ν = 1625.10(C = N), 1229.86 (C-N), 2964.65(CH), 1445.35 (C-O-C). 1H NMR (400 MHz, CDCl3, ppm) δ = 8.437 (s, 1H, CH), 3.197 (s, 4H, N-(CH2)2), 3.880 (s, 4H, O-(CH2)2, 6.661–8.078(m, 9H, Ar-H). 13C NMR (100 MHz, CDCl3, ppm) δ = 155.68 (C = N), 49.31(N-CH2), 66.09(O-CH2), 116.06-150.28 (Ar-C). Anal. C (76.66), H (6.81), N (10.52); Found (%): C (76.61), H (6.77), N (10.50). LCMS (m/z) = 345[M1+], 347[M2+], 265,189,182,176, 168, 162, 156, 91, 79, 77, 27.
( E )-N-(4-Bromobenzylidene)-4-morpholinoaniline (3): FT- IR (KBr, cm− 1); ν = 1620.93(C = N), 1232.12 (C-N), 2958.23(CH), 1487.12 (C-O-C). 1H NMR (400 MHz, CDCl3, ppm) δ = 8.446(s, 1H, CH), 3.192 (s, 4H, N-(CH2)2), 3.880 (s, 4H, O-(CH2)2, 6.934–7.764(m, 9H, Ar-H). 13C NMR (100 MHz, CDCl3, ppm) δ = 156.18 (C = N), 49.36(N-CH2), 66.89(O-CH2), 116.10-150.16 (Ar-C). Anal. C (76.66), H (6.81), N (10.52); Found (%): C (76.61), H (6.77), N (10.50). LCMS (m/z) = 345[M1+], 347[M2+], 265, 189, 182, 176, 168, 162, 156, 91, 79, 77, 27.
( E )-N-(3-Chlorobenzylidene)-4-morpholinoaniline (4): FT- IR (KBr, cm− 1); ν = 1619.68(C = N), 1245.23 (C-N), 2954.19 (CH), 1467.14 (C-O-C). 1H NMR (400 MHz, CDCl3, ppm) δ = 8.447 (s, 1H, CH), 3.194 (s, 4H, N-(CH2)2), 3.878 (s, 4H, O-(CH2)2, 6.936–7.918(m, 9H, Ar-H). 13C NMR (100 MHz, CDCl3, ppm) δ = 155.80 (C = N), 49.55(N-CH2), 66.42(O-CH2), 116.11-150.21 (Ar-C). Anal. C (76.66), H (6.81), N (10.52); Found (%): C (76.61), H (6.77), N (10.50). LCMS (m/z) = 300[M+], 302[M2+], 265, 214, 189, 176, 162, 138, 124, 111, 86, 77, 35, 27.
( E )-N-(4-Chlorobenzylidene)-4-morpholinoaniline (5): FT- IR (KBr, cm− 1); ν = 1620.85(C = N), 1265.17 (C-N), 2962.47 (CH), 1465.195 (C-O-C). 1H NMR (400 MHz, CDCl3, ppm) δ = 8.460 (s, 1H, CH), 3.192 (s, 4H, N-(CH2)2), 3.880 (s, 4H, O-(CH2)2, 6.935–7.833(m, 9H, Ar-H). 13C NMR (100 MHz, CDCl3, ppm) δ = 156.12 (C = N), 49.38(N-CH2), 66.90(O-CH2), 116.11-150.14 (Ar-C). Anal. C (76.66), H (6.81), N (10.52); Found (%): C (76.61), H (6.77), N (10.50). LCMS (m/z) = 300[M+], 302 [M2+], 265, 214, 189, 176, 162, 138, 124, 111, 104, 86, 77, 35, 27.
( E )-N-(4-Dimethylaminobenzylidene)-4-morpholinoaniline (6): FT- IR (KBr, cm− 1); ν = 1607.92(C = N), 1238.28 (C-N), 2954.29(CH), 1438.18 (C-O-C). 1H NMR (400 MHz, CDCl3, ppm) δ = 8.351 (s, 1H, CH), 3.167 (s, 4H, N-(CH2)2), 3.879 (s, 4H, O-(CH2)2, 6.723–7.769(m, 9H, Ar-H), 3.052(s, 6H, (CH3)2). 13C NMR (100 MHz, CDCl3, ppm) δ = 157.60 (C = N), 49.55(N-CH2), 66.93(O-CH2), 19.43 (CH3), 116.25–149.90 (Ar-C). Anal. C (76.66), H (6.81), N (10.52); Found (%): C (76.61), H (6.77), N (10.50). LCMS (m/z) = 309[M+], 294, 279, 265, 223, 189, 179, 176, 162, 147, 133, 120, 103, 86, 76, 44, 30, 15 .
( E )-N-(4-Fluorobenzylidene)-4-morpholinoaniline (7): FT- IR (KBr, cm− 1); ν = 1622.51(C = N), 1232.39 (C-N), 2970.13(CH), 1447.44 (C-O-C). 1H NMR (400 MHz, CDCl3, ppm) δ = 8.457 (s, 1H, CH), 3.123 (s, 4H, N-(CH2)2), 3.891 (s, 4H, O-(CH2)2, 6.944–7.766(m, 9H, Ar-H). 13C NMR (100 MHz, CDCl3, ppm) δ = 156.27 (C = N), 49.45(N-CH2), 66.91(O-CH2), 115.77–150.00 (Ar-C). Anal. C (76.66), H (6.81), N (10.52); Found (%): C (76.61), H (6.77), N (10.50). LCMS (m/z) = 284[M+], 286[M2+], 265, 198, 179, 176, 162, 122, 108, 103, 95, 91, 89, 77, 27, 19.
( E )-N-(3-Methoxybenzylidene)-4-morpholinoaniline (8): FT- IR (KBr, cm− 1); ν = 1621.74(C = N), 1288.79 (C-N), 2958.12(CH), 1467.29(C-O-C). 1H NMR (400 MHz, CDCl3, ppm) δ = 8.467 (s, 1H, CH), 3.889 (s, 4H, N-(CH2)2), 3.889 (s, 4H, O-(CH2)2, 6.938–7.509(m, 9H, Ar-H), 3.188(s, 3H, OCH3). 13C NMR (100 MHz, CDCl3, ppm) δ = 157.77 (C = N), 49.47(N-CH2), 66.92(O-CH2), 55.52 (OCH3), 111.63-149.98 (Ar-C). Anal. C (76.66), H (6.81), N (10.52); Found (%): C (76.61), H (6.77), N (10.50). LCMS (m/z) = 265[M+], 210, 184, 179, 162, 134, 128, 120, 107, 103, 91, 89, 77, 31, 15.
( E )-N-(2-Methylbenzylidene)-4-morpholinoaniline (9): FT- IR (KBr, cm− 1); ν = 1617.44(C = N), 1247.29 (C-N), 2971.09(CH), 1442.19(C-O-C). 1H NMR (400 MHz, CDCl3, ppm) δ = 8.446 (s, 1H, CH), 3.184 (s, 4H, N-(CH2)2), 3.883 (s, 4H, O-(CH2)2, 6.935–7.788(m, 9H, Ar-H), 2.425(s, 3H, CH3). 13C NMR (100 MHz, CDCl3, ppm) δ = 156.66 (C = N), 49.55(N-CH2), 66.93(O-CH2), 19.43 (CH3), 116.25–149.90 (Ar-C). Anal. C (76.66), H (6.81), N (10.52); Found (%): C (76.61), H (6.77), N (10.50). LCMS (m/z) = 280 [M1+], 265, 194, 189, 179, 176, 162, 118, 103, 91, 89, 85, 77, 27, 15.
( E )-N-(4-Methylbenzylidene)-4-morpholinoaniline (10): FT- IR (KBr, cm− 1); ν = 1619.41(C = N), 1246.32 (C-N), 2969.14(CH), 1462.76(C-O-C). 1H NMR (400 MHz, CDCl3, ppm) δ = 8.457 (s, 1H, CH), 3.180 (s, 4H, N-(CH2)2), 3.8789 (s, 4H, O-(CH2)2, 6.932–7.785(m, 9H, Ar-H), 2.411(s, 3H, CH3). 13C NMR (100 MHz, CDCl3, ppm) δ = 157.97 (C = N), 49.55(N-CH2), 66.94(O-CH2), 29.73 (CH3), 116.22-149.79 (Ar-C). Anal. C (76.66), H (6.81), N (10.52); Found (%): C (76.61), H (6.77), N (10.50). LCMS (m/z) = 280[M+], 265, 194, 189, 179, 176, 162, 118, 103, 91, 89, 85, 77, 27, 15.
( E )-N-(4-Nitrobenzylidene)-4-morpholinoaniline (11): FT- IR (KBr, cm− 1); ν = 1597.73(C = N), 1288.23(C-N), 2978.25(CH), 1469.24(C-O-C). 1H NMR (400 MHz, CDCl3, ppm) δ = 8.598 (s, 1H, CH), 3.226 (s, 4H, N-(CH2)2), 3.886 (s, 4H, O-(CH2)2, 6.951–8.322(m, 9H, Ar-H). 13C NMR (100 MHz, CDCl3, ppm) δ = 158.93 (C = N), 49.85(N-CH2), 66.99(O-CH2), 116.98-149.98 (Ar-C). Anal. C (76.66), H (6.81), N (10.52); Found (%): C (76.61), H (6.77), N (10.50). LCMS (m/z) = 311 [M+], 265, 225, 189, 179, 176, 162, 149, 135, 122, 103, 89, 86, 77, 46, 27.
The characteristic spectral frequencies of (E)-3,5-Dibromo-2-((4-substituted phenylimino) methyl) anilines (11–17) are summarized in Table 2.
Table 2 The infrared, NMR and Mass spectral data of (E)-3,5-Dibromo-2-((4-substituted phenylimino) methyl) anilines (11-17).
Entry | Substt. | IR (ν, cm− 1) | 1H NMR (δ, ppm) | 13C NMR (δ, ppm) | Mass(m/z) |
NH | C = N | NH | CH | Subtt. | C = N | Subtt. |
12 | H | 3378.64 | 1616.97 | 4.185 | 8.314 | --- | 155.66 | --- | 354[M+], 356[M2+], 358[M4+], 336, 273, 262, 248, 245, 232,196, 194, 117, 104, 91, 79, 77, 24, 16 |
13 | Br | 3329.22 | 1635.59 | 4.253 | 8.513 | --- | 155.21 | --- | 433[M+], 435[M2+], 437[M4+], 439[M6+], 414, 351, 335, 275, 262, 259, 248, 245, 232, 182, 169, 155, 79, 77, 16 |
14 | Cl | 3361.96 | 1633.99 | 4.179 | 8.511 | --- | 155.21 | --- | 388[M+], 390[M2+], 392[M4+], 394[M6+], 360, 307, 291, 272, 256, 245, 232, 196, 182, 138, 125, 111, 79, 77, 35, 16 |
15 | F | 3264.03 | 1613.46 | 4.901 | 8.507 | --- | 155.20 | --- | 372[M+], 374[M2+], 376[M4+], 378[M6+], 357, 351, 276, 274, 259, 248, 245, 232, 181, 167, 154, 122, 109, 95, 79, 27, 19, 16. |
16 | OCH3 | 3391.30 | 1637.18 | 4.085 | 8.314 | 3.385 | 155.66 | 52.08 | 414[M+], 416[M2+], 418[M4+], 366, 351, 335, 287, 278, 261, 259, 245, 234, 134, 121, 107, 91, 79, 77, 31, 16, 15. |
17 | CH3 | 3448.71 | 1636.35 | 4.066 | 8.523 | 2.356 | 155.25 | 27.05 | 368[M+], 370[M2+], 372[M4+], 350, 271, 259, 245, 232, 180, 166, 153, 118, 105, 91, 79, 77, 27, 16, 15 |
Molecular docking analysis
Auto Dock Tools-1.5.7 was employed to run docking interactions on different substituted imine derivatives with breast cancer protein. The Protein Data Bank (PDB) was utilized to acquire the crystal structure of human estrogen receptor (PDB ID: 2IOK) [45–47]. The Protein Data Bank (PDB) delivered the crystal structure of the protein receptor, which was assisted in this work. The ligand structures were constructed in the CDX format by using Chem Draw ultra-version 8.0. Open Babel-2.5.7 was exploited to convert the prepared ligand in CDX format into PDB format. Next, a PDBQT file was arranged, grid box size and center were placed. Kollman charges and polar hydrogen atoms were added to the protein structure of 2IOK. The grid size was position at 80, 90, 80 (x, y, and z) points respectively. This file was pinned and stored in PDBQT format. Ligand binding affinities were noticed as negative Gibbs free energy (ΔG) scores (kcal/mol). The docking pose analysis was detected with Discovery studio, which displays the binding sites, hydrogen-bonding interactions, hydrophobic interactions, and bond distances.
Measurement of Antibacterial activity
The antimicrobial activities of the imines (1–11) were measured using the standard Bauer-Kirby[48] disc diffusion method. There are each three gram positive and gram negative microbes were used for the measurement of the antibacterial activities of the synthesized E-N-(substituted benzylidene)(-4-morpholinanilines(1–11) such as, Bacillus subtilis, Micrococcus luteus, Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa and Klebsiella pneumoniae. In each petri-plate about 0.5 mL of the test bacterial sample was spread uniformly over the solidified Mueller-Hinton agar using sterile glass spreader. Then the disc with 5 mm diameter made up of Whatman No. 1 filter paper, impregnated with the solution of the compound were placed on the medium using sterile forceps. The plates were incubated for 24 h at 37°C by keeping the plates upside down to prevent the collection of water droplets over the medium. After 24 h the plates were visually examined and the diameter values of the zone of inhibition were measured. Triplicate results were recorded by repeating the same procedure.
Measurement of Antifungal activity
Antifungal activities of the synthesized E-N-(substituted benzylidene)(4-morpholinanilines (1–11) were measured using three fungal strains such as Aspergillus niger, Mucor species and Trichoderma viride. The PDA medium was prepared and sterilized as above. It was poured (ear bearing heating condition) in the petri-plate, which was already filled with 1 mL of the fungal species. The plate was rotated clockwise and counter clockwise for uniform spreading of the species. The disc was impregnated with the test solution. The test solution was prepared by dissolving 15 mg of the imine in 1 mL of DMSO solvent. The medium was allowed to solidify and kept for 24 h. Then the plates were visually examined and the diameter values of zone of inhibition were measured. Triplicate results were recorded by repeating the same procedure.
Measurement of Antimalarial activity
Procedure: Parasite culture: The P. falciparum Thailand strain Thai and strain K1 used for this cell culture [38–42]. Culture was grown in complete medium consisting RPMI1640 supplemented with 11mM glucose, 27.5 mM medium hydrogen carbonate, 100 UI/ml penicillin, 100 µL/ml streptomycin and 8% heat-inactivated human serum albumin. Parasites was grown at 37°C, in human A + red blood cells (RBCs) at a 2% hematocrit, under 3% CO2, 6% oxygen and 91% nitrogen atmosphere. The in vitro assays were performed cultures with a 3–6% parasitemia as determined by counting parasites on Giemsa-stained smears.
Inhibition Tests
Increasing concentration of the synthesized imines were dissolved in dimethyl sulfoxide (DMSO) and tested for their inhibitory effect towards the P. falciparum intraerythrocytic development. Parasites were allowed to grow at 37°C for 24h in a candle jar, the 0.5µCi 3H-hypoxanthine was added per well. After an additional 24 h incubation period, plates are freeze thawed and harvested on filters. Dried filters were moistened in scintillation liquid mixture and counted in a 1450 Microbeta counter. The growth inhibition in percent was calculated from the parasite associated radioactivity. Hundred percent 3H-hypoxanthine incorporation was determined from control growth in the absence of the retinoid-like chalcones. Values for the IC50 were determined. Each mean concentration was estimated from three different experiment sets.